Browsing Department of Pharmaceutical Engineering by Subject "adjuvant therapy; Akt signaling; basal like breast cancer; brain metastasis; breast cancer; breast cancer recurrence; cancer incidence; cancer prognosis; cancer regression; cancer resistance; colon cancer; disease free survival; distant metastasis; drug bioavailability; drug delivery system; drug formulation; drug penetration; drug solubility; encapsulation; epithelial mesenchymal transition; gene expression profiling; hedgehog signaling; human; lung cancer; lung metastasis; lymphocytopenia; metastatic breast cancer; molecularly targeted therapy; monotherapy; nanoemulsion; nanomedicine; non-canonical Wnt signaling; nonhuman; Notch signaling; ovary cancer; overall survival; partial mastectomy; personalized medicine; progression free survival; Review; self emulsifying drug delivery system; TGF beta signaling; triple negative breast cancer; tumor invasion; tumor microenvironment; visceral metastasis"

Browsing Department of Pharmaceutical Engineering by Subject "adjuvant therapy; Akt signaling; basal like breast cancer; brain metastasis; breast cancer; breast cancer recurrence; cancer incidence; cancer prognosis; cancer regression; cancer resistance; colon cancer; disease free survival; distant metastasis; drug bioavailability; drug delivery system; drug formulation; drug penetration; drug solubility; encapsulation; epithelial mesenchymal transition; gene expression profiling; hedgehog signaling; human; lung cancer; lung metastasis; lymphocytopenia; metastatic breast cancer; molecularly targeted therapy; monotherapy; nanoemulsion; nanomedicine; non-canonical Wnt signaling; nonhuman; Notch signaling; ovary cancer; overall survival; partial mastectomy; personalized medicine; progression free survival; Review; self emulsifying drug delivery system; TGF beta signaling; triple negative breast cancer; tumor invasion; tumor microenvironment; visceral metastasis"

Sort by: Order: Results:

  • Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC) 
    Chaudhuri, Aiswarya; Kumar, Dulla Naveen; Dehari, Deepa; Singh, Sanjay; Kumar, Pradeep; Bolla, Pradeep Kumar; Kumar, Dinesh; Agrawal, Ashish Kumar (MDPI, 2022-05)
    Triplenegative breast cancer (TNBC) is considered one of the unmanageable types of breast cancer, involving devoid of estrogen, progesterone, and human epidermal growth factor receptor 2 (HER 2) receptors. Due to their ...

Search in IDR


Advanced Search

Browse

My Account